UroLiftSystem的优势 •简单的操作过程 •轻微的创伤 •较短的治疗周期 •治疗后不需要使用导尿管,或导尿管留置时间极短 •保护患者性功能 •治疗效果维持时间长 •快速缓解症状,术后2周左右产生效果 1.Roehrborn,CanJUrol2015,3-YearL.I.F.T.Study 2.Roehrborn,UrologyPractice2015,2-YearL.I....
[3] “First U.S. Patient Treated Following FDA Clearance of NeoTract’s UroLift System” https://www.neotract.com/posts/news/ [4] “Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)” https://www.urolift.com/pr...
Access a wealth of information and events on the UroLift® System for health care professionals in Hong Kong. Empower your practice today.
The UroLift Delivery Device is removed, leaving an open urethra to provide symptom relief. Advantages of the UroLift SystemBecause the UroLift System is a minimally invasive, outpatient procedure, there is minimal associated downtime. Typically, there is no need to place a catheter. The procedure ...
Using add-on codes:CPT code 52441 is used to report the initial UroLift System implant and add-on CPT code 52442 reports each additional implant. The number of implants will vary by patient due to the unique characteristics of the prostate and prostatic urethra. ...
Treatment with the UroLift System is usually done on a day case basis or as an outpatient treatment; small implants are used to keep the blocked pathway that impedes the flow of urine open, so that the blockage is addressed and the symptoms of the enlarged prostate (BPH) do not have to ...
Teleflex™ thrives on shared values, with people at the center of all we do. Learn more about the company, and the UroLift™ System.
Treatment with the UroLift System is usually done on an day case basis or as an outpatient treatment; small implants are used to keep the blocked pathway that impedes the flow of urine open, so that the blockage is addressed and the symptoms of the enlarged prostate (BPH) do not have to...
[3] "First U.S. Patient Treated Following FDA Clearance of NeoTract's UroLift System" https://www.neotract.com/posts/news/ [4] "Teleflex Announces Regulatory Clearance for its UroLift® System inChinafor the Treatment of Benign Prostatic Hyperplasia (BPH)" https://www.urolift.com/press-rel...
生产商美国新域公司NeoTract, Inc.对经尿道植入前列腺束钉UroLift System(注册证编号:国械注进20223130205)主动召回。召回级别为二级。涉及产品的型号、规格及批次等详细信息见《医疗器械召回事件报告表》。 2022年8月10日